Prostate Cancer Stem Cells and Their Role in Tumor Formation
Author Information
Author(s): Hurt E M, Kawasaki B T, Klarmann G J, Thomas S B, Farrar W L
Primary Institution: National Cancer Institute at Frederick, National Institutes of Health
Hypothesis
CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
Conclusion
CD44+CD24− prostate cells are identified as stem-like cells responsible for tumor initiation and have a genomic signature predictive of poor patient prognosis.
Supporting Evidence
- CD44+CD24− cells can form colonies in soft agar and tumors in mice.
- These cells express genes important for stem cell maintenance.
- Gene expression patterns of CD44+CD24− cells predict poor prognosis in prostate cancer patients.
Takeaway
Some prostate cancer cells can act like stem cells, helping tumors grow and making it harder to treat cancer. These special cells can be used to study how to fight prostate cancer better.
Methodology
Flow cytometry was used to isolate CD44+CD24− prostate cells, which were then analyzed for their tumorigenic properties in NOD/SCID mice and gene expression patterns.
Limitations
The study primarily focuses on specific cell lines and may not fully represent the complexity of prostate cancer in patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website